Is There Evidence That Oral Hypoglycemia Agents Reduce Cardiovascular Morbidity/Mortality? Yes

被引：22

作者：

Bianchi, Cristina ^{[1
]}

Miccoli, Roberto ^{[1
]}

Daniele, Giuseppe ^{[1
]}

Penno, Giuseppe ^{[1
]}

Del Prato, Stefano ^{[1
]}

机构：

[1] Univ Pisa, Dept Endocrinol & Metab, Sect Diabet & Metab Dis, Pisa, Italy

来源：

DIABETES CARE | 2009年 / 32卷

关键词：

LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; TYPE-2; DIABETES-MELLITUS; CORONARY-HEART-DISEASE; RISK-FACTORS; VASCULAR COMPLICATIONS; CONSENSUS STATEMENT; MORTALITY; METAANALYSIS; ROSIGLITAZONE;

D O I：

10.2337/dc09-S336

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：S342 / S348

页数：7

共 53 条

[1]

DPP-4 inhibitors [J].

Ahren, Bo .

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) :517-533

[2]

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death - A population-based study of 13000 men and women with 20 years of follow-up [J].

Almdal, T ;

Scharling, H ;

Jensen, JS ;

Vestergaard, H .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (13) :1422-1426

[3]

Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome [J].

Bianchi, Cristina ;

Penno, Giuseppe ;

Malloggi, Lucia ;

Barontini, Rossana ;

Corfini, Marisa ;

Giovannitti, Maria G. ;

Di Cianni, Graziano ;

Del Prato, Stefano ;

Miccoli, Roberto .

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (01) :31-38

[4]

Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes [J].

Bianchi, Cristina ;

Penno, Giuseppe ;

Pancani, Francesca ;

Civitelli, Alessia ;

Piaggesi, Alberto ;

Caricato, Francesco ;

Pellegrini, Giovanni ;

Del Prato, Stefano ;

Miccoli, Roberto .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (02) :246-253

[5]

Biochemistry and molecular cell biology of diabetic complications [J].

Brownlee, M .

NATURE, 2001, 414 (6865) :813-820

[6]

Glycemic targets and cardiovascular disease [J].

Cefalu, William T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) :2633-2635

[7]

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].

Chiasson, JL ;

Josse, RG ;

Gomis, R ;

Hanefeld, M ;

Karasik, A ;

Laakso, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494

[8]

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors [J].

Chiquette, E ;

Ramirez, G ;

DeFronzo, R .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (19) :2097-2104

[9]

The relationship between glucose and incident cardiovascular events [J].

Coutinho, M ;

Gerstein, HC ;

Wang, Y ;

Yusuf, S .

DIABETES CARE, 1999, 22 (02) :233-240

[10]

DELPRATO S, 2005, METABOLIC SYNDROME B, P180

← 1 2 3 4 5 6 →